Page last updated: 2024-08-26

bosentan anhydrous and Hand Dermatosis

bosentan anhydrous has been researched along with Hand Dermatosis in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (36.36)29.6817
2010's7 (63.64)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abuowda, Y; Almeida, RS; Matos-Costa, J; Oliveira, AA; Pego, P; Santos, C1
Belz, D; Hunzelmann, N; Moinzadeh, P1
Matucci-Cerinic, M; Seibold, JR1
Ambach, A; Bonnekoh, B; Gollnick, H; Seo, W1
Denton, CP; Matucci-Cerinic, M; Pope, JE; Steen, V1
Black, CM; Carpentier, P; Denton, CP; Doyle, MK; Fessler, BJ; Furst, DE; Hellmich, B; Hsu, VM; Korn, JH; Kramer, F; Matucci-Cerinic, M; Mayes, MD; Medsger, TA; Merkel, PA; Morganti, A; Pope, JE; Seibold, JR; Sweiss, NJ; Wigley, FM1
Weinerth, J; Wiesent, F1
Pope, J; Zelenietz, C1
Kurgyis, Z; Lang, MU; Ruzicka, T; Sárdy, M; Sick, I; Varga, R1
Hasegawa, M; Hattori, T; Ishikawa, O; Nagai, Y; Okada, E; Tago, O1
Varga, J1

Reviews

3 review(s) available for bosentan anhydrous and Hand Dermatosis

ArticleYear
Digital ulcers and outcomes assessment in scleroderma.
    Rheumatology (Oxford, England), 2008, Volume: 47 Suppl 5

    Topics: Bosentan; Fingers; Hand Dermatoses; Humans; Iloprost; Ischemia; Scleroderma, Systemic; Severity of Illness Index; Skin Ulcer; Sulfonamides; Treatment Outcome; Vasodilator Agents

2008
Digital ulcers: overt vascular disease in systemic sclerosis.
    Rheumatology (Oxford, England), 2009, Volume: 48 Suppl 3

    Topics: Antihypertensive Agents; Bosentan; Databases, Factual; Endothelium, Vascular; Fingers; Hand Dermatoses; Humans; Raynaud Disease; Scleroderma, Systemic; Skin Ulcer; Sulfonamides

2009
Differences in disability as measured by the Health Assessment Questionnaire between patients with and without digital ulcers in systemic sclerosis: a post hoc analysis of pooled data from two randomised controlled trials in digital ulcers using bosentan.
    Annals of the rheumatic diseases, 2010, Volume: 69, Issue:11

    Topics: Antihypertensive Agents; Bosentan; Disability Evaluation; Fingers; Hand Dermatoses; Humans; Randomized Controlled Trials as Topic; Scleroderma, Systemic; Skin Ulcer; Sulfonamides

2010

Trials

2 trial(s) available for bosentan anhydrous and Hand Dermatosis

ArticleYear
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial.
    Annals of the rheumatic diseases, 2011, Volume: 70, Issue:1

    Topics: Adult; Bosentan; Double-Blind Method; Drug Administration Schedule; Endothelin Receptor Antagonists; Female; Fingers; Hand Dermatoses; Humans; Male; Middle Aged; Scleroderma, Systemic; Skin Ulcer; Sulfonamides; Treatment Outcome; Wound Healing

2011
New hope for systemic sclerosis patients with digital ulcers.
    Current rheumatology reports, 2005, Volume: 7, Issue:2

    Topics: Administration, Oral; Bosentan; Chemical and Drug Induced Liver Injury; Double-Blind Method; Endothelin Receptor Antagonists; Fingers; Foot Dermatoses; Hand Dermatoses; Humans; Scleroderma, Localized; Scleroderma, Systemic; Skin Ulcer; Sulfonamides; Toes; Treatment Outcome

2005

Other Studies

6 other study(ies) available for bosentan anhydrous and Hand Dermatosis

ArticleYear
Treatment of digital ulcers in systemic sclerosis: Case series study of thirteen patients and discussion on outcome.
    Revista da Associacao Medica Brasileira (1992), 2017, Volume: 63, Issue:5

    Topics: Aged; Aged, 80 and over; Alprostadil; Bosentan; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Female; Fingers; Hand Dermatoses; Humans; Male; Middle Aged; Reproducibility of Results; Scleroderma, Systemic; Skin Ulcer; Sulfonamides; Time Factors; Treatment Outcome; Vasodilator Agents; Wound Healing

2017
[Digital ulcers in systemic scleroderma].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2014, Volume: 65, Issue:11

    Topics: Bosentan; Fingers; Hand Dermatoses; Humans; Iloprost; Phosphodiesterase 5 Inhibitors; Scleroderma, Systemic; Skin Ulcer; Sulfonamides; Wound Healing

2014
Low-dose combination therapy of severe digital ulcers in diffuse progressive systemic sclerosis with the endothelin-1 receptor antagonist bosentan and the phosphodiesterase V inhibitor sildenafil.
    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2009, Volume: 7, Issue:10

    Topics: Aged; Bosentan; Drug Therapy, Combination; Endothelin Receptor Antagonists; Female; Fingers; Hand Dermatoses; Humans; Phosphodiesterase Inhibitors; Piperazines; Purines; Scleroderma, Diffuse; Sildenafil Citrate; Sulfonamides; Sulfones; Treatment Outcome; Ulcer

2009
[Digital ulcers in systemic sclerosis--an interdisciplinary challenge].
    Medizinische Klinik (Munich, Germany : 1983), 2010, Volume: 105, Issue:8

    Topics: Angiography; Antihypertensive Agents; Arm; Bosentan; Cooperative Behavior; CREST Syndrome; Endothelin Receptor Antagonists; Fatal Outcome; Fingers; Follow-Up Studies; Hand Dermatoses; Humans; Iloprost; Interdisciplinary Communication; Leg; Male; Middle Aged; Scleroderma, Limited; Skin Ulcer; Sulfonamides; Vasodilator Agents

2010
Bosentan is effective against digital ulcerations and hyperkeratosis in systemic sclerosis.
    Acta dermato-venereologica, 2011, Volume: 91, Issue:6

    Topics: Antihypertensive Agents; Bosentan; Female; Hand Dermatoses; Humans; Keratosis; Middle Aged; Raynaud Disease; Scleroderma, Systemic; Skin Ulcer; Sulfonamides

2011
Bosentan for digital ulcers in patients with systemic sclerosis.
    The Journal of dermatology, 2012, Volume: 39, Issue:1

    Topics: Adult; Aged; Antihypertensive Agents; Bosentan; Chemical and Drug Induced Liver Injury; Female; Hand Dermatoses; Humans; Male; Middle Aged; Scleroderma, Systemic; Skin Ulcer; Sulfonamides; Treatment Outcome; Young Adult

2012